로딩 중…
지수 로딩 중…
Sam Chun Dang Pharm. Co., Ltd
000250· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩253,500-3.61%
2026-06-19
Price Chart
Sam Chun Dang Pharm. Co., Ltd+57.26%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 5.95T KRW |
| Revenue | 246.05B KRW |
| Net Income | 18.46B KRW |
| Total Assets | 573.12B KRW |
| Net Assets | 394.47B KRW |
| Employees | 417 |
| Value | |
| P/E | 322.17x |
| P/B | 15.07x |
| PEG | 0.24x |
| P/S | 24.17x |
| EV/EBITDA | 446.56x |
| FCF Yield | -0.61% |
| Profitability | |
| ROE | 4.68% |
| ROA | 3.22% |
| Op. Margin | 5.38% |
| Revenue Growth | 28.15% |
| Earnings Growth | 1344.03% |
| Financial Health | |
| Debt Ratio | 145.29% |
| Total Debt | 44.71B KRW |
| FCF | -36.35B KRW |
| Cash | 84.21B KRW |
| Current Ratio | 2.18x |
| Net Debt/EBITDA | -2.99x |
| Dividend | |
| Div. Yield | 0.02% |
| Div. Growth | -75.00% |
| Performance | |
| 1Y Return | 57.26% |
| 1M Return | -26.95% |
| From 52W High | -79.44% |
| 1Y MDD | -79.81% |
| Trading | |
| Volume | 136,094 shares |
| Foreign Own. | 6.83% |
| Per Share | |
| EPS | 436 KRW |
| BPS | 12,740 KRW |
Company Info
Samchundang Pharm, established in 1943 and headquartered in Hwaseong-si, Gyeonggi-do, began as a pharmaceutical manufacturer and seller. By acquiring Optus Pharm in 2013, it became a leading specialized ophthalmic treatment company, producing prescription-based pharmaceuticals including antibiotics, circulatory disease treatments, digestive disease treatments, and eye drops. The company is actively expanding its global market presence by exporting finished pharmaceuticals to Vietnam, Hong Kong, and Singapore.